TTOO (T2 Biosystems) Cyclically Adjusted FCF per Share: $-249.36 (As of Sep. 2024)


TTOO T2 Biosystems Inc TTOO
12 GF Score
Price $0.00
View Full Analysis

What is T2 Biosystems Cyclically Adjusted FCF per Share?

T2 Biosystems TTOO 12 Cyclically Adjusted FCF per Share is $-249.36 as of Sep. 2024. GuruFocus rates TTOO with a GF Score™ of 12/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

T2 Biosystems's adjusted free cash flow per share for the three months ended in Sep. 2024 was $-0.349. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $-249.36 for the trailing ten years ended in Sep. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2026-07-02), T2 Biosystems's current stock price is $0.002. T2 Biosystems's Cyclically Adjusted FCF per Share for the quarter that ended in Sep. 2024 was $-249.36. T2 Biosystems's Cyclically Adjusted Price-to-FCF of today is .


T2 Biosystems  (OTCPK:TTOO) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


T2 Biosystems Cyclically Adjusted FCF per Share Related Terms


T2 Biosystems Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for T2 Biosystems's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T2 Biosystems Cyclically Adjusted FCF per Share Chart

T2 Biosystems Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -257.94 -260.99

T2 Biosystems Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -266.03 -260.99 -260.26 -257.00 -249.36

TTOO vs IDTA, NSTM, TMO: Cyclically Adjusted FCF per Share Comparison

For the Diagnostics & Research subindustry, T2 Biosystems's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


T2 Biosystems Cyclically Adjusted Price-to-FCF vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, T2 Biosystems's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where T2 Biosystems's Cyclically Adjusted Price-to-FCF falls into.


TTOO
12GF Score
T2 Biosystems Inc TTOO
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

T2 Biosystems Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, T2 Biosystems's adjusted Free Cash Flow per Share data for the three months ended in Sep. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.349/315.3010*315.3010
=-0.349

Current CPI (Sep. 2024) = 315.3010.

T2 Biosystems Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201412 -47.650 234.812 -63.983
201503 -44.050 236.119 -58.822
201506 -62.670 238.638 -82.803
201509 -64.872 237.945 -85.962
201512 -50.207 236.525 -66.929
201603 -57.826 238.132 -76.565
201606 -57.473 241.018 -75.186
201609 -51.108 241.428 -66.746
201612 -36.695 241.432 -47.922
201703 -47.056 243.801 -60.856
201706 -42.655 244.955 -54.905
201709 -37.564 246.819 -47.986
201712 -30.507 246.524 -39.018
201803 -32.772 249.554 -41.406
201806 -23.909 251.989 -29.916
201809 -23.847 252.439 -29.785
201812 -21.159 251.233 -26.555
201903 -29.483 254.202 -36.569
201906 -20.473 256.143 -25.201
201909 -30.454 256.759 -37.398
201912 -21.180 256.974 -25.987
202003 -21.585 258.115 -26.367
202006 -11.264 257.797 -13.777
202009 -4.419 260.280 -5.353
202012 -6.164 260.474 -7.461
202103 -6.009 264.877 -7.153
202106 -6.910 271.696 -8.019
202109 -5.838 274.310 -6.710
202112 -6.034 278.802 -6.824
202203 -425.588 287.504 -466.735
202206 -288.686 296.311 -307.187
202209 -267.150 296.808 -283.795
202212 -140.068 296.797 -148.801
202303 -96.029 301.836 -100.313
202306 -15.352 305.109 -15.865
202309 -2.994 307.789 -3.067
202312 -2.327 306.746 -2.392
202403 -2.293 312.332 -2.315
202406 -0.656 314.175 -0.658
202409 -0.349 315.301 -0.349

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $-249.36 mean?
T2 Biosystems (TTOO) has a Cyclically Adjusted FCF per Share of $-249.36 as of Sep. 2024. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on T2 Biosystems and its competitors.
Is T2 Biosystems' Cyclically Adjusted FCF per Share too high?
T2 Biosystems' current Cyclically Adjusted FCF per Share is $-249.36. Overall, T2 Biosystems has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does T2 Biosystems' Cyclically Adjusted FCF per Share compare to IDTA and NSTM?
T2 Biosystems' Cyclically Adjusted FCF per Share of $-249.36 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Diagnostics & Research company?
A good Cyclically Adjusted FCF per Share depends on the Medical Diagnostics & Research industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on T2 Biosystems and its competitors. T2 Biosystems's current Cyclically Adjusted FCF per Share is $-249.36. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T2 Biosystems stock overvalued right now?
T2 Biosystems (TTOO) has a current Cyclically Adjusted FCF per Share of $-249.36. The current Cyclically Adjusted FCF per Share is $-249.36. T2 Biosystems' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For T2 Biosystems (TTOO), the current Cyclically Adjusted FCF per Share is $-249.36 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

T2 Biosystems Business Description

Address 101 Hartwell Avenue, Lexington, MA, USA, 02421
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
12GF Score

Get the complete analysis for TTOO

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price